This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Fabienne Treilhou: Innovator in Gene Expression Systems
Introduction
Fabienne Treilhou is a notable inventor based in Gif sur Yvette, France. He has made significant contributions to the field of gene expression, particularly through his innovative work on the tyrosine hydroxylase gene. His research has implications for various applications, including gene therapy.
Latest Patents
Treilhou holds a patent for a derived tyrosine hydroxylase gene expression system. This invention discloses a new system for gene expression that utilizes derived sequences of the first intron of the tyrosine hydroxylase gene, which possess transcription-enhancing properties. The system is particularly useful in the production of proteins in vitro, ex vivo, or in vivo, especially in gene therapy applications. He has 1 patent to his name.
Career Highlights
Fabienne Treilhou has worked at Aventis Pharma S.A., where he has been involved in groundbreaking research and development in the pharmaceutical industry. His work has contributed to advancements in therapeutic techniques and methodologies.
Collaborations
Throughout his career, Treilhou has collaborated with notable colleagues, including Jacques Mallet and Rolando Meloni. These collaborations have further enriched his research and innovation in the field.
Conclusion
Fabienne Treilhou is a distinguished inventor whose work in gene expression systems has the potential to impact gene therapy significantly. His contributions to the field are noteworthy and continue to inspire future innovations.